NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,608 | -2.6% | 25,084 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $186,374 | +7.2% | 25,084 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $173,832 | -32.6% | 25,084 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $257,864 | -73.2% | 25,084 | -52.6% | 0.00% | -76.9% |
| Q3 2022 | $963,000 | +19.8% | 52,907 | +238.3% | 0.01% | +18.2% |
| Q2 2022 | $804,000 | +3.5% | 15,638 | +48.2% | 0.01% | +22.2% |
| Q1 2022 | $777,000 | -56.3% | 10,551 | -15.2% | 0.01% | -57.1% |
| Q4 2021 | $1,780,000 | +73.7% | 12,438 | +151.6% | 0.02% | +425.0% |
| Q3 2021 | $1,025,000 | +101.0% | 4,944 | -94.3% | 0.00% | -55.6% |
| Q2 2019 | $510,000 | – | 86,956 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |